Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Becher
Benjamin John Becher, San Jose, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100091039 | COLOR CORRECTION OF ELECTRONIC DISPLAYS - A method for adjusting the characteristics of a display. The method for adjusting the characteristics of the display may include constructing color models as a function of a parameter such as temperature. Furthermore, the color model may be used to determine adjustment values to be applied to a display. The adjustment values may be organized in a table as a function of temperature and color values. The adjustment values may be determined from measurements. | 04-15-2010 |
Burkhard Becher, Maur CH
| Patent application number | Description | Published |
|---|---|---|
| 20080292590 | Soluble Receptors and Methods for Treating Autoimmune or Demyelinating Diseases - The present invention relates to novel therapeutic protein useful in the treatment of diseases, in particular in human subjects. The results of the inventor strongly support the use of soluble IL-18Rα in the treatment of diseases such as autoimmune or demyelinating disease, in particular Multiple Sclerosis (MS). Accordingly, the invention provides soluble IL-18Rα for use in the treatment of autoimmune or demyelinating disease, in particular MS. The invention also provides methods of treating, preventing or ameliorating the symptoms of autoimmune or demyelinating disease, in particular MS, in a subject, preferably a human subject, by administering a therapeutically effective amount of said soluble IL-18Rα to the subject. | 11-27-2008 |
| 20080317710 | Methods For Treating Autoimmune or Demyelinating Diseases - The present invention relates to novel therapeutic or prophylactic treatment in human subjects. The present invention results in part from the discovery that antagonists of IL-18Rα are effective in vivo for treating diseases. Accordingly, the invention provides a method of treating, preventing or ameliorating the symptoms of an autoimmune or demyelinating disease (such as multiple sclerosis) in a subject, preferably a human subject, said method comprising administering to the subject a therapeutically effective amount of an antagonist of IL-18Rα. The invention also pertains to the use of an antagonist of IL-18Rα in the manufacture of a medicament for the treatment of an autoimmune or demyelinating diseases (such as multiple sclerosis). | 12-25-2008 |
Mariela Paula Becher, Buenos Aires AR
| Patent application number | Description | Published |
|---|---|---|
| 20100152244 | SELF-EMULSIFYING FORMULATION OF TIPRANAVIR FOR ORAL ADMINISTRATION - A self-emulsifying formulation of tipranavir for oral administration. | 06-17-2010 |
Paul F. Becher, Oak Ridge, TN US
| Patent application number | Description | Published |
|---|---|---|
| 20100267543 | USE OF ADDITIVES TO IMPROVE MICROSTRUCTURES AND FRACTURE RESISTANCE OF SILICON NITRIDE CERAMICS - A high-strength, fracture-resistant silicon nitride ceramic material that includes about 5 to about 75 wt-% of elongated reinforcing grains of beta-silicon nitride, about 20 to about 95 wt-% of fine grains of beta-silicon nitride, wherein the fine grains have a major axis of less than about 1 micron; and about 1 to about 15 wt-% of an amorphous intergranular phase comprising Si, N, O, a rare earth element and a secondary densification element. The elongated reinforcing grains have an aspect ratio of 2:1 or greater and a major axis measuring about 1 micron or greater. The elongated reinforcing grains are essentially isotropically oriented within the ceramic microstructure. The silicon nitride ceramic exhibits a room temperature flexure strength of 1,000 MPa or greater and a fracture toughness of 9 MPa-m | 10-21-2010 |